Gillams A R
Department of Medical Imaging, The Middlesex Hospital, Mortimer Street, London, W1T 3AA, UK.
Cancer Imaging. 2005 Sep 21;5(1):103-9. doi: 10.1102/1470-7330.2005.0015.
Several different technologies have been employed for the local ablation of tissue by thermal techniques. At the present time the most widely favoured technique is radiofrequency ablation (RFA) but developments in other techniques, e.g. microwave may change this. In many countries RFA or percutaneous ethanol injection (PEI) are accepted therapies for patients with Childs Pugh Class A or B cirrhosis and early hepatocellular carcinoma (HCC). Results for RFA in large series of patients with liver metastases from colon cancer are very promising. Five-year survival rates of 26% from the time of first ablation and 30% from the diagnosis of liver metastases for patients with limited (<6, <5 cm) liver disease who are not surgical candidates compares well with post resection series where 5-year survival rates vary between 29% and 39% in operable candidates. Sufficient experience has now been gained in lung and renal ablation to show that these are minimally invasive techniques which can produce effective tumour destruction with a limited morbidity. More novel areas for ablation such as adrenal or pelvic recurrence are being explored.
已经采用了几种不同的技术通过热技术对组织进行局部消融。目前,最受青睐的技术是射频消融(RFA),但其他技术(如微波)的发展可能会改变这种情况。在许多国家,RFA或经皮乙醇注射(PEI)是Childs Pugh A级或B级肝硬化和早期肝细胞癌(HCC)患者的公认治疗方法。大量结肠癌肝转移患者的RFA治疗结果非常有前景。对于不适合手术的局限性(<6个,<5厘米)肝病患者,首次消融后5年生存率为26%,从肝转移诊断起为30%,与手术切除系列相比效果良好,可手术患者的5年生存率在29%至39%之间。现在在肺和肾消融方面已经积累了足够的经验,表明这些是微创技术,可以在发病率有限的情况下有效破坏肿瘤。正在探索更多新颖的消融领域,如肾上腺或盆腔复发。